Projects per year
Fingerprint
Dive into the research topics where David Page is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 6 Active
-
T-cell receptor DNA deep sequencing as a novel immune-based biomarker in early stage breast cancer.
Page, D. (PI)
01/1/15 → …
Project: Research
-
A combined screening approach of Fracture (Fx) Risk Algorithm (FRAX) and Trabecular Bone Score (TBS) to identify osteoporotic-range fracture risk (ORFR) in breast cancer (BC) patients treated with adjuvant aromatase inhibitor (AI)
Page, D. (PI)
American Society of Clinical Oncology
01/1/15 → …
Project: Research
-
3 Things You Should Know About Circulating (Cell-Free) Tumor DNA in Breast Cancer From the International Congress on the Future of Breast Cancer 2025 Annual Meeting
Page, D. & Razavi, P., Mar 16 2026, In: Oncology (Williston Park, N.Y.). 40, 1, p. 48-51 4 p.Research output: Contribution to journal › Article › peer-review
-
Clinical potential and challenges of spatially profiling tumor-infiltrating lymphocytes in early-stage breast cancer
Page, D. B., Simanonok, M., Hanes, D. A. & Su, A., Mar 2026, In: PLOS Medicine. 23, 3 March, e1004979.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Integration of molecular subtyping and immune profiling to predict pathologic complete response in HER2+ breast cancer treated with neoadjuvant dual HER2 therapy.
Page, D. B., Elkhanany, A., Samiian, L., Elayoubi, J., Layeequr Rahman, R., Dias, E., Santillan, A. A., Brown, E. A., Gold, L. P., Matt-Amaral, L. B., Dekhne, N., Lesnikoski, B. A., Hampton, R., Conter, H. J., Uygun, S., Stivers, N., Menicucci, A., Audeh, W. & O'Shaughnessy, J., Jun 2026, In: Journal of Clinical Oncology. 44, 16, p. 621 1 p.Research output: Contribution to journal › Article › peer-review
-
Peri-lymphatic cytokines (IRX-2) as immunologic induction preceding neoadjuvant chemo-immunotherapy in triple-negative breast cancer
Su, A., Hong, E. C., Moxon, N., Mellinger, S. L., Kelly, T., Conlin, A. K., Topp, Z. Z., Newell, P., Fredrich, N., Massimino, K. P., Wu, Y., Martel, M., Redmond, W. L., Aliabadi-Wahle, S., Sun, Z., Imatani, J., Stanton, S. E., Hanes, D. A., Simanonok, M. & Rosales, W. & 2 others, , Dec 2026, In: npj Breast Cancer. 12, 1, 66.Research output: Contribution to journal › Article › peer-review
Open Access -
Development of a highly sensitive ctDNA assay to map the evolution of metastatic breast cancer.
Kaplan, H. G., Wagner, J., Dowdell, A. K., Welle, J., Reynolds, S., Cosgrove, B., Carney, C. G., Page, D. B., McCormick, K. A., Yan, F., Conlin, A. K., Johnston, E., File, D. M., Wahl, T. A., Topp, Z., Paulson, K. G., Xie, B., Montgomery, S., Lopez, J. P. & Piening, B., Jun 2025, In: Journal of Clinical Oncology. 43, p. e13048-e13048Research output: Contribution to journal › Review article › peer-review
Open Access